<DOC>
	<DOCNO>NCT01029249</DOCNO>
	<brief_summary>Oral human papillomavirus ( HPV ) oral wart common health concern HIV-infected people . This study examine frequency oral HPV DNA shed oral wart HIV-infected people enrol ACTG A5257 begin treatment highly active antiretroviral therapy ( HAART ) .</brief_summary>
	<brief_title>Examining Incidence Oral Human Papillomavirus ( HPV ) Shedding Oral Warts After Beginning HAART HIV-Infected Adults</brief_title>
	<detailed_description>Oral HPV infection occur high rate among HIV-infected people among general population . Recent research United States Europe also find HIV-infected people high risk oral oropharyngeal squamous cell cancer HIV-uninfected people . In one study , find HPV seropositivity associate increase risk squamous cell carcinoma oropharynx ( SCCOP ) . In addition SCCOP , another HPV-related health concern oral wart , condition effective treatment . Even begin treatment highly active antiretroviral therapy ( HAART ) , active HPV replication mouth oropharynx may persist HIV-infected people , lead increase risk SCCOP oral wart . The purpose study evaluate frequency oral HPV DNA shed oral wart HIV-infected people prior HAART initiation regular time point HAART initiation . ACTG A5257 study compare effectiveness three non-nucleoside reverse transcriptase inhibitor ( NNRTI ) -sparing HAART regimens treatment-na√Øve participant . This study enroll participant ACTG A5257 study . Participants attend baseline study visit time ACTG A5257 baseline study visit . At baseline Week 4 , 16 , 24 , 48 study visit , participant undergo examination mouth , throat wash saliva collection , behavioral questionnaire . A blood collection also occur Week 24 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Meet inclusion criterion enrol ACTG A5257 Ability willingness participant legal guardian/representative provide inform consent Coenrollment A5260s Has begin receive HAART part A5257 study Has ever receive HPV vaccine plan receive HPV vaccine 6 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>